心房颤动的抗凝治疗
Antithrom botic therapy for atrial fibrillation
出处
《实用药物与临床》
CAS
2005年第4期3-5,共3页
Practical Pharmacy and Clinical Remedies
参考文献20
-
1马长生,周玉杰,马煜,郑知刚,颜红兵,王勇,李霄,柯元南,汤旦林.北京地区非瓣膜病心房颤动患者缺血性脑卒中发生率及影响因素的随访研究[J].中华心血管病杂志,2002,30(3):165-167. 被引量:148
-
2戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
-
3Wattigney WA,Mensah GA,Croft JB.Increasing Trends in Hospitalization for Atrial Fibrillation in the United States,1985 Through 1999 Implications for Primary Prevention[J].Circulation,2003,108:711-716.
-
4Petersen P.Thromboembolic complications in atrial fibrillation[J].Stroke,1990,21:4-13.
-
5胡大一,孙艺红,周自强,李奎宝,倪永斌,杨光,孙淑红,李蕾.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志,2003,42(3):157-161. 被引量:361
-
6Peterson P,Boysen G,Gotfriedsen J,et al.Placebo-controlled,randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.The Copenhagen AFASAK Study[J].Lancet,1989,1:175-179.
-
7The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation.N Engl J Med[J].1990,323:1505-1511.
-
8Stroke Prevention in Atrial Fibrillation Investigators.Stroke Prevention in Atrial Fibrillation Study: Final results[J].Circulation,1991,84:527-539.
-
9Connolly SJ,Laupacis A,Gent M,et al.Canadian Atrial Fibrillation Anticoagulation (CAFA) Study[J].J Am Coll Cardiol ,1991,18:349-355.
-
10Ezekowitz MD,Bridgers SL,James KE,et al.Warfarin in the prevention of stroke associated with nonreumatic atrial fibrillation[J].N Engl J Med,1992,327:1406-1412.
二级参考文献10
-
1Saoudi N,Schoels W,EL-Sherif N,eds.Atrial flutter and fibrillation:from basic to clinical applications[]..1998
-
2Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study[].Stroke.1991
-
3Caro JJ,Flegel KM,Orejuela ME,et al.Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice[].Canadian Medical Association Journal.1999
-
4Flegel KM,Shipley MJ,Rise G.Risk of stroke in non-rheumatic atrial fibrillation[].The Lancet.1987
-
5Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation[].Stroke.2000
-
6Hart RG,Sherman DG,Easton JD,et al.Prevention of stroke in patients with nonvalvular atrial fibrillation[].Neurology.1998
-
7Peterson P,Boysen G,Godtfredsen J,et al.Placebo controlled,randomized trial of warfarin and aspirin for prevention of thromboembolic complications on chronic atrial fibrillation: the Compenhagen AFASAK study[].The Lancet.1989
-
8Feinberg WM,Blackshear JL,Laupacis A,et al.Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications[].Archives of Internal Medicine.1995
-
9Ezekowitz MD,Bridgers SL,James KE,et al.Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation:Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators[].The New England Journal of Medicine.1992
-
10Connolly SJ,Laupacis A,Gent M,et al.Canadian atrial fibrillation anticoagulation (CAFA) study[].Journal of the American College of Cardiology.1991
共引文献762
-
1顾智淳,张在丽,刘晓琰.1例胺碘酮致华法林国际标准化比值升高的病例分析[J].医药导报,2015,34(S01):172-173. 被引量:1
-
2亓自强,司东明,杨建军.脑卒中的影响因素及治疗现状[J].世界最新医学信息文摘,2020(50):76-77. 被引量:3
-
3卢建平.96例老年心房颤动患者的临床诊疗体会[J].临床研究,2014,22(11):29-29.
-
4李永玲.心房颤动的研究新进展[J].实用医技杂志,2007,14(9):1212-1214. 被引量:1
-
5陈钟良,陈丽娜,成银宏,唐欧杉,周浩亮,吴群伟,秦丰明.心房颤动病人起搏器植入术后可早期使用华法林[J].岭南心血管病杂志,2006,12(6):417-418.
-
6Hang Zhao Yong Lin Wenhua Qi Shuping Yin Jiachun Feng.Alternation in F-wave parameters of median nerve from unaffected extremity in stroke patients with hemiplegia under dynamic state[J].Neural Regeneration Research,2006,1(9):806-808.
-
7龚冰璐,黄红漫.心房颤动的基础研究和临床治疗新进展[J].心血管病学进展,2006,27(z1):106-108.
-
8赵琼琼,柳茵.高血压伴心房颤动患者脑钠肽的变化与肾素血管紧张素醛固酮系统的关系[J].青海医药杂志,2008,38(4):1-3. 被引量:3
-
9卫文喜.房颤患者抗凝治疗临床分析[J].实用医技杂志,2008,15(23):3122-3123.
-
10胡大一,周自强,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状流行病学研究[J].中国心脏起搏与心电生理杂志,2004(z1):3-6. 被引量:32
-
1杜昕,刘晓惠,马长生.心房颤动的药物治疗[J].中华心律失常学杂志,2005,9(2):129-132. 被引量:33
-
2郑龙,梅元武.心房颤动所致缺血性卒中与抗凝治疗的研究现状[J].现代医药卫生,2011,27(7):1027-1028. 被引量:2
-
3肖光明,祝武辉,阳唤军.基层医院心房颤动的抗凝治疗现状及对策[J].实用医技杂志,2007,14(33):4641-4642. 被引量:2
-
4丁同斌,刘士超,简立国.老年心房颤动并发脑梗死127例分析及抗凝治疗[J].中国实用神经疾病杂志,2016,19(13):75-76. 被引量:2
-
5对管理新发现房颤患者的建议[J].中华全科医师杂志,2009,8(9):652-652.
-
6郝长宁,陈颖敏.老年心房颤动患者华法林治疗的效果与风险[J].中国心脏起搏与心电生理杂志,2010,24(3):260-262. 被引量:7
-
7钟卉.当糖尿病患者遭遇心律失常[J].糖尿病之友,2007(11):27-27.
-
8“中国房颤联盟”项目启动[J].中华医学信息导报,2013(6):6-6.
-
9心房颤动抗凝治疗中国专家共识[J].中华内科杂志,2012,51(11):916-921. 被引量:139
-
10张维,吴毓敏,刘千军,韩维嘉,郭新贵.社区老年非瓣膜性心房颤动患者的抗凝治疗现状[J].国际心血管病杂志,2016,43(3):187-189. 被引量:5